My ePortfolio Register   
Filter results by:

Showing: Treatments / Antibodies & immunotherapy

Conference Report: Highlights from the Inaugural International Cancer Microbiome Consortium Meeting (ICMC), 5–6 September 2017, London, UK

Abstract | Full Article | PDF Published: 20 Dec 2017 / https://doi.org/10.3332/ecancer.2017.791

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 / https://doi.org/10.3332/ecancer.2017.770

Review: Dual role of inflammatory mediators in cancer

Abstract | Full Article | PDF Published: 23 Feb 2017 / https://doi.org/10.3332/ecancer.2017.721

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Abstract | Full Article | PDF Published: 16 Dec 2016 / https://doi.org/10.3332/ecancer.2016.703

Conference Report: Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

Abstract | Full Article | PDF Published: 09 Nov 2016 / https://doi.org/10.3332/ecancer.2016.691

Clinical Study: Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

Abstract | Full Article | PDF Published: 29 Sep 2016 / https://doi.org/10.3332/ecancer.2016.676

Conference Report: Highlights from the 2016 WIN Symposium, 27–29 June 2016, Paris: personalised therapy beyond next-generation sequencing

Abstract | Full Article | PDF Published: 24 Aug 2016 / https://doi.org/10.3332/ecancer.2016.669

Review: Role of nanotechnology and gene delivery systems in TRAIL based therapies

Abstract | Full Article | PDF Published: 01 Aug 2016 / https://doi.org/10.3332/ecancer.2016.660

Review: Cancer-associated thrombotic microangiopathy

Abstract | Full Article | PDF Published: 28 Jun 2016 / https://doi.org/10.3332/ecancer.2016.649

Case Report: Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?

Abstract | Full Article | PDF Published: 07 Jun 2016 / https://doi.org/10.3332/ecancer.2016.646



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence